0
0
9/17/23 at 5:32pm
Organization
Livemint
Author
Ujjval Jauhari
22 words
0
Comments
Weakness in domestic growth is driven by slow growth in the acute segment
You are the first to view
https://www.livemint.com/industry/manufacturing/weak-pharma-growth-in-q2-sparks-concerns-11694971766632.html
Create an account
or login to join the discussion